Evidence map›Paper›PMID 37601048›Full record

ReviewFrontiers in pharmacology2023

Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent.

Vijay Laxmi Trivedi, Ruchi Soni, Praveen Dhyani, Priyanka Sati, Silvia Tejada, Antoni Sureda, William N Setzer, Ahmad Faizal Abdull Razis, Babagana Modu, Monica Butnariu and 1 more

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Molecular structure of 3-Beilstein journal of organic chemistry · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Serendipity in Neuro-Oncology: The Evolution of Chemotherapeutic Agents.International journal of molecular sciences · 2025
    Review
  13. Exploring Volatiles and Biological Effects ofMolecules (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Frontiers in pharmacology · 2025
    Article
  16. Article
  17. Article
  18. Frontiers in pharmacology · 2023
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vijay Laxmi TrivediHigh Altitude Plant Physiology Research Centre (HAPPRC), HNB. Garhwal University (A Central University), Srinagar Garhwal, Uttarakhand, India.
Ruchi SoniRegional Centre for Organic and Natural Farming, Ghaziabad, Uttar Pradesh, India.
Praveen DhyaniInstitute for Integrated Natural Sciences, University of Koblenz, Koblenz, Germany.
Priyanka SatiDepartment of Biotechnology, Kumaun University, Bhimtal, Uttarakhand, India.
Silvia TejadaLaboratory of Neurophysiology, Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain.
Antoni SuredaLaboratory of Neurophysiology, Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain.
William N SetzerAromatic Plant Research Center, Lehi, UT, United States.
Ahmad Faizal Abdull RazisDepartment of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, Selangor, Malaysia.
Babagana ModuNatural Medicines and Products Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, Selangor, Malaysia.
Monica ButnariuUniversity of Life Sciences "King Mihai I" From Timisoara, Timis, Romania.
Javad Sharifi-RadFacultad de Medicina, Universidad del Azuay, Cuenca, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the advent of highly effective plant-based medications with few or no side effects, the use of phytomedicines against complex diseases such as cancer is becoming more widespread. The broadly recognized pentacyclic triterpenes known as boswellic acids (BAs) are derived from the oleogum resin, or frankincense, extracted from the plant species of the genus

Indexed as

apoptosisbioactive compoundsBoswelliacancertriterpenes

Identifiers

PMID37601048
PMCPMC10434769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.